Osimert 80 MG (Osimertinib) – 30 Tablets
Osimert 80 mg is used to treat metastatic EGFR T790M mutation-positive non-small cell lung cancer in patients who have progressed on EGFR TKI therapy.
- The description claims that Osimert 80 mg is indicated for treating patients with metastatic EGFR T790M mutation-positive non-small cell lung cancer.
AI Readiness
Good foundation, but some important product data is still missing.
72%